Year1
- 价格：
- 700
- 规格：
- 60MG
- 包装：
- 28片
Daclatasvir is a revolutionary new drug for hepatitis C combined with sofosbuvir or other preparations. Daclatasvir is The first complex inhibitor, in combination with other drugs, offers shorter treatment duration (weeks or weeks), lower side effects, and better efficacy than regimens based on interferon and ribavirin.
After the United States developed sofosbuvir at the end of the year and became a super blockbuster in the field of hepatitis C, daclatasvir was developed by Bristol-Myers Squibb in 2011 and became a blockbuster in the history of hepatitis C. Sofosbuvir is Complex inhibitors, daclatasvir complex inhibitors, the combination of the two can effectively kill hepatitis C virus. Current relevant experiments have proven that the cure rate of hepatitis C with sofosbuvir combined with daclatasvir can reach %% .
The good news is that the much-anticipated new drug daclatasvir for hepatitis C has been launched in India in mid-2020. We can currently supply it at a very affordable price per box.
The combination of sofosbuvir + daclatasvir can effectively kill the hepatitis C virus. Current relevant experiments have proven that the cure rate of sofosbuvir + daclatasvir for hepatitis C is as high as over %.
Daclatasvir produced by Indian Pharmaceuticals was approved by the Drug Regulatory Authority of India on March 21, 2019, and is allowed to be marketed in India. Its trade name is that it will form a genotypic combination treatment plan with the previously produced sofosbuvir. This time, the Indian company won the first place. However, it was obviously not to be outdone. In just a few days, its products, Jierdai and daclatasvir, were selected.
Due to its high popularity among Chinese patients, more Chinese patients will choose this product as their first choice. In fact, both Daclatasvir and other regular pharmaceutical manufacturers in India are very good products. As long as % genuine drugs can be obtained from legal channels, they can achieve a cure rate of more than %.
It is a very large generic drug manufacturer in India. Its pharmaceutical technology is world-famous, with standard production workshops and strict quality control. Its company produces sofosbuvir, daclatasvir, and second-generation drug. All are produced under the authorization of the original manufacturer, with guaranteed quality and more affordable prices. Consult for details
Daclatasvir
Specifications of tablets
Japan* tablets/box, the price of a course of treatment is RMB
South Korea* tablets/box, the price of a course of treatment is RMB
Bangladesh* tablets/box, the price of a treatment box is RMB yuan
Bangladesh* tablets/box, the price of a treatment box is RMB yuan
India* tablets/box, the price of a treatment box is RMB yuan
WhatsApp
